findmyKOL
Clinical trialNCT05815810Not, yet, recruitingInterventional

Novel Delivery Method of Transgender Voice Modification Training Using a Mobile Application

SponsorWeill Medical College of Cornell UniversityEnrollment50Transitioning Voice of Transgender and Gender Diverse People
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ithaca College

    Ithaca, New York, United States

    David Bayne, PhD, CCC-SLP
  • Weill Cornell Medicine

    New York, New York, United States

    Anaïs Rameau, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2026
Primary completion
31 Dec 2030
Completion
31 Dec 2031
Last update posted
22 Jun 2026
Registered enrollment
50
Registry id
NCT05815810

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.